tirzepatide in chinese Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment Mounjaro (Tirzepatide) | Professional Medical

References : Parks M, Rosebraugh C

Effect of obesity on the pharmacokinetics of drugs in humans

The drug is recommended for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater and who at least one weight-related ailment, or in patients with a BMI of 30 kg/m2 or greater

Peptides are short chains of amino acids that serve as essential signaling molecules in the bodyregulating biological functions, supporting healing, reducing inflammation, improving muscle growth and recovery , and promoting longevity

The FDA recommends Wegovy for weight loss if you have a BMI of 27kg/m2 or greater along with weight-related conditions like high blood pressure, Type 2 diabetes, or high cholesterol, or a BMI of 30kg/m2 or higher